These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 23302184)

  • 1. Letter to the Editor: Shopping frenzy induced by naltrexone--a paradoxical effect in bipolar disorder?
    Losekam S; Kluge I; Nittel KS; Kircher T; Konrad C
    Psychol Med; 2013 Apr; 43(4):895. PubMed ID: 23302184
    [No Abstract]   [Full Text] [Related]  

  • 2. Naltrexone for individuals with comorbid bipolar disorder and alcohol dependence.
    Sonne SC; Brady KT
    J Clin Psychopharmacol; 2000 Feb; 20(1):114-5. PubMed ID: 10653225
    [No Abstract]   [Full Text] [Related]  

  • 3. Naltrexone in patients with bipolar disorder and alcohol dependence.
    Brown ES; Beard L; Dobbs L; Rush AJ
    Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone in bipolar disorder with depression: a double-blind, placebo-controlled study.
    Murphy BL; Ravichandran C; Babb SM; Cohen BM
    J Clin Psychopharmacol; 2014 Dec; 34(6):749-51. PubMed ID: 25310199
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter To The Editor - Drug Eruption After Sustained Release Naltrexone Pellet Implantation.
    Ak S; Can Gürel Ş
    Turk Psikiyatri Derg; 2020; 31(2):146-147. PubMed ID: 32594504
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Sablaban IM; Sivananthan M
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):620. PubMed ID: 33146546
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.
    Grant JE; Kim SW; Odlaug BL
    Biol Psychiatry; 2009 Apr; 65(7):600-6. PubMed ID: 19217077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone-bupropion combination therapy for protracted abstinence dysphoria.
    Williams J; Ziedonis DM
    Am J Addict; 2003; 12(3):270-2. PubMed ID: 12851023
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of naltrexone on sleep parameters in healthy male volunteers.
    Sramek J; Andry JM; Ding H; Riordan HJ; Leibowitz M; Cutler NR
    J Clin Psychopharmacol; 2014 Feb; 34(1):167-8. PubMed ID: 24346745
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alcohol dependence treatment with naltrexone: safety assessment. Observation study group of alcoholic dependence].
    Ochoa Mangado E; Arias Horcajadas F; Torres Hernández MA
    Actas Esp Psiquiatr; 2000; 28(3):161-8. PubMed ID: 11000698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
    Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
    Willemsen-Swinkels SH; Buitelaar JK; van Engeland H
    Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of undesirable effects during the use of opiate antagonists].
    Rust M
    Klin Anasthesiol Intensivther; 1993; 42():108-16. PubMed ID: 8450619
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategies to maximize the efficacy of naltrexone for alcohol dependence.
    O'Malley SS
    NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
    Petrakis IL; Nich C; Ralevski E
    Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Naltrexone--high expectations to low dosages].
    Raknes G; Giverhaug T
    Tidsskr Nor Laegeforen; 2011 May; 131(8):844-6. PubMed ID: 21556092
    [No Abstract]   [Full Text] [Related]  

  • 17. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
    Poser W; Ehrenreich H
    Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
    [No Abstract]   [Full Text] [Related]  

  • 18. Blame the counselling, not the implant. A response to Oliver, Horspool & Keen (2005).
    Kunøe N; Lobmaier P
    Addiction; 2005 Jul; 100(7):1027-8; author reply 1028-9. PubMed ID: 15955020
    [No Abstract]   [Full Text] [Related]  

  • 19. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
    Fishman M
    Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone (vivitrol)--a once-monthly injection for alcoholism.
    Med Lett Drugs Ther; 2006 Jul; 48(1240):63-4. PubMed ID: 16874283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.